Medication for Adolescents and Young Adults With Opioid Use Disorder [PDF]
Journal of Adolescent Health, 2021 Opioid-related morbidity and mortality have risen in many settings globally. It is critical that practitioners who work with adolescents and young adults (AYAs) provide timely, evidence-based treatment for opioid use disorder (OUD). Such treatment should include medications for opioid use disorder (MOUD), including buprenorphine, naltrexone, and ...
Kreida, Ellen C. +9 more
openaire +4 more sources
Leveraging pharmacy partnerships and Grant funding to improve access to medications for opioid use disorder [PDF]
Exploratory Research in Clinical and Social PharmacyBackground: Increased availability and access to FDA-approved medications for opioid use disorder (MOUD) can improve efforts to address the ongoing opioid public health crisis.
John M. Vasko +6 more
doaj +2 more sources
271 Evaluation of treatment for opioid use disorder across North Carolina: a study protocol [PDF]
Journal of Clinical and Translational ScienceOBJECTIVES/GOALS: Our objectives are to: 1) characterize opioid treatment providers in North Carolina according to payment methods accepted and ability to provide medications for opioid use disorder and 2) use geomapping technology to characterize ...
Rachel Lynn Graves +3 more
doaj +2 more sources
Receipt of medications for opioid use disorders among veterans by race/ethnicity and legal involvement: an observational study of electronic health records [PDF]
Health & JusticeBackground The Veterans Health Administration has made strides to improve access to medications for opioid use disorder overall. However, quality improvement methods to assess treatment gaps may not sufficiently detect differences in medication access by
Andrea K. Finlay +7 more
doaj +2 more sources
Concurrent opioid and alcohol withdrawal management [PDF]
Mental Health Clinician, 2023 Concurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies.
Michelle Colvard, PharmD, BCPP
doaj +1 more source
Medication Treatment of Opioid Use Disorder [PDF]
Biological Psychiatry, 2020 Opioid use disorder (OUD) is a chronic, relapsing condition, often associated with legal, interpersonal, and employment problems. Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and naltrexone (an opioid antagonist).
James Bell, John Strang
openaire +5 more sources
Medications for opioid use disorder shape immune responses during chronic HIV infection [PDF]
Cell Reports MedicineSummary: People living with HIV (PLWHs) have higher risk of opioid use disorder (OUD). Whether medications for opioid use disorder (MOUDs) change immune responses in HIV infection is unknown.
Jack A. Collora +10 more
doaj +2 more sources
Medications Development for Treatment of Opioid Use Disorder [PDF]
Cold Spring Harbor Perspectives in Medicine, 2020 This review describes methods for preclinical evaluation of candidate medications to treat opioid use disorder (OUD). The review is founded on the propositions that (1) drug self-administration procedures provide the most direct method for assessment of medication effectiveness, (2) procedures that assess choice between opioid and nondrug reinforcers ...
E. Andrew Townsend +2 more
openaire +2 more sources
The Evolving Medicolegal Precedent for Medications for Opioid Use Disorder in U.S. Jails and Prisons. [PDF]
, 2021 Medications for opioid use disorder, also known as medication-assisted treatment (MAT), are critical in the treatment of opioid use disorder. Historically, inmates with opioid use disorder in U.S.
McNiel, Dale E +3 more
core +1 more source
Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals.
JAMA Netw OpenThis cross-sectional study examines the availability of medications for opioid use disorder in psychiatric hospitals in the US.
Cohen SM +3 more
europepmc +3 more sources